Efficient expansion of rare human circulating hematopoietic stem/progenitor cells in steadystate blood using a polypeptide-forming 3D culture

Abstract

Although widely applied in treating hematopoietic malignancies, transplantation of hematopoietic stem/progenitor cells (HSPCs) is impeded by HSPC shortage. Whether circulating HSPCs (cHSPCs) in steady-state blood could be used as an alternative source remains largely elusive. Here we develop a three-dimensional culture system (3DCS) including arginine, glycine, aspartate, and a series of factors. Fourteen-day culture of peripheral blood mononuclear cells (PBMNCs) in 3DCS led to 125- and 70-fold increase of the frequency and number of CD34⁺ cells. Further, 3DCS-expanded cHSPCs exhibited the similar reconstitution rate compared to CD34⁺ HSPCs in bone marrow. Mechanistically, 3DCS fabricated an immunomodulatory niche, secreting cytokines as TNF to support cHSPC survival and proliferation. Finally, 3DCS could also promote the expansion of cHSPCs in patients who failed in HSPC mobilization. Our 3DCS successfully expands rare cHSPCs, providing an alternative source for the HSPC therapy, particularly for the patients/donors who have failed in HSPC mobilization.

Keywords

hematopoietic stem/progenitor cell transplantation / peripheral blood mononuclear cells / expansion / mobilization / three-dimensional culture / selfrenewal and multilineage differentiation

References

[1] Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR et al (2019) Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 20: 163- 172

[2] Bai T, Li J, Sinclair A, Imren S, Merriam F, Sun F, O’Kelly MB, Nourigat C, Jain P, Delrow JJ et al (2019) Expansion of primitive human hematopoietic stem cells by culture in a zwitterionic hydrogel. Nat Med 25: 1566- 1575

[3] Bensinger W, DiPersio JF, McCarty JM (2009) Improving stem cell mobilization strategies: future directions. Bone Marrow Transplant 43: 181- 195

[4] Bodine DM, Karlsson S, Nienhuis AWJPotNAoS. (1989) Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. PNAS 86: 8897- 8901

[5] Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, Denison MS et al (2010) Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329: 1345- 1348

[6] Boulais PE, Frenette PS (2015) Making sense of hematopoietic stem cell niches. Blood 125: 2621- 2629

[7] Calvi LM, Link DC (2015) The hematopoietic stem cell niche in homeostasis and disease. Blood 126: 2443- 2451

[8] De Angeli S, Di Liddo R, Buoro S, Toniolo L, Conconi MT, Belloni AS, Parnigotto PP, Nussdorfer , G.G.J.I.j.o.m.m. (2004) New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. Int J Mol Med 13: 363- 371

[9] Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R (2020) Cell PhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc 15: 1484- 1506

[10] Espin-Palazon R, Stachura DL, Campbell CA, Garcia-Moreno D, Del Cid N, Kim AD, Candel S, Meseguer J, Mulero V, Traver D (2014) Proinflammatory signaling regulates hematopoietic stem cell emergence. Cell 159: 1070- 1085

[11] Ferreira MS, Jahnen-Dechent W, Labude N, Bovi M, Hieronymus T, Zenke M, Schneider RK, Neuss S (2012) Cord blood-hematopoietic stem cell expansion in 3D fibrin scaffolds with stromal support. Biomaterials 33: 6987- 6997

[12] Forristal CE, Nowlan B, Jacobsen RN, Barbier V, Walkinshaw G, Walkley CR, Winkler IG, Levesque JP (2015) HIF-1alpha is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1alpha. Leukemia 29: 1366- 1378

[13] Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M et al (2021) Integrated analysis of multimodal single-cell data. Cell 184: 3573- 3587

[14] Haylock DN, Williams B, Johnston HM, Liu MC, Rutherford KE, Whitty GA, Simmons PJ, Bertoncello I, Nilsson SK (2007) Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells 25: 1062- 1069

[15] Hequet O (2015) Hematopoietic stem and progenitor cell harvesting:technical advances and clinical utility. J Blood Med 6: 55- 67

[16] Hu Y, Smyth GK (2009) ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347: 70- 78

[17] Ishida T, Suzuki S, Lai CY, Yamazaki S, Kakuta S, Iwakura Y, Nojima M, Takeuchi Y, Higashihara M, Nakauchi H et al (2017) PreTransplantation Blockade of TNF-alpha-Mediated Oxygen Species Accumulation Protects Hematopoietic Stem Cells. Stem Cells 35: 989- 1002

[18] Ku H, Yonemura Y, Kaushansky K, Ogawa M (1996) Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87: 4544- 4551

[19] Luo Y, Xiao H, Lai X, Shi J, Tan Y, He J, Xie W, Zheng W, Zhu Y, Ye X et al (2014) T-cell-replete haploidentical HSCT with low-dose antiT-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood 124: 2735- 2743

[20] Majeti R, Park CY, Weissman IL (2007) Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1: 635- 645

[21] Massberg S, Schaerli P, Knezevic-Maramica I, Kollnberger M, Tubo N, Moseman EA, Huff IV, Junt T, Wagers AJ, Mazo IB et al (2007) Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 131: 994- 1008

[22] Massberg S, von Andrian UH (2009) Novel trafficking routes for hematopoietic stem and progenitor cells. Ann N Y Acad Sci 1176: 87- 93

[23] Mayani H, Alvarado-Moreno JA, Flores-Guzman P (2003) Biology of human hematopoietic stem and progenitor cells present in circulation. Arch Med Res 34: 476- 488

[24] McKinney-Freeman S, Goodell MA (2004) Circulating hematopoietic stem cells do not efficiently home to bone marrow during homeostasis. Exp Hematol 32: 868- 876

[25] Mimeault M, Hauke R, Batra SK (2007) Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82: 252- 264

[26] Mohty M, Hubel K, Kroger N, Aljurf M, Apperley J, Basak GW, Bazarbachi A, Douglas K, Gabriel I, Garderet L et al (2014) Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 49: 865- 872

[27] Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JEJS (2011) Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333: 218- 221

[28] Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A (2010) Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191: 677- 691

[29] Pearl-Yafe M, Mizrahi K, Stein J, Yolcu ES, Kaplan O, Shirwan H, Yaniv I, Askenasy N (2010) Tumor necrosis factor receptors support murine hematopoietic progenitor function in the early stages of engraftment. Stem Cells 28: 1270- 1280

[30] Perseghin P, Terruzzi E, Dassi M, Baldini V, Parma M, Coluccia P, Accorsi P, Confalonieri G, Tavecchia L, Verga L et al (2009) Management of poor peripheral blood stem cell mobilization:incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions. Transfus Apher Sci 41: 33- 37

[31] Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N et al (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3: 687- 694

[32] Pronk CJ, Veiby OP, Bryder D, Jacobsen SE (2011) Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J Exp Med 208: 1563- 1570

[33] Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C (2017a) Single-cell mRNA quantification and differential analysis with Census. Nat Methods 14: 309- 315

[34] Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C (2017b) Reversed graph embedding resolves complex single-cell trajectories. Nat Methods 14: 979- 982

[35] Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL (2003) A role for Wnt signalling in selfrenewal of haematopoietic stem cells. Nature 423: 409- 414

[36] Schreier S, Triampo W (2020) The blood circulating rare cell population. What is it and what is it good for?. Cells 9 (4): 790

[37] Shan W, Wang B, Xu Y, Li X, Li X, Wang H, Lin Y, Tie R, Zhao Q, Wang J et al (2020) Generation of hematopoietic cells from mouse pluripotent stem cells in a 3D culture system of selfassembling peptide hydrogel. J Cell Physiol 235: 2080- 2090

[38] Shan W, Yu Q, Long Y, Luo Q, Li H, Han Y, Xu Y, Fu S, Zeng X, Wei C et al (2021) Enhanced HSC-like cell generation from mouse pluripotent stem cells in a 3D induction system cocultured with stromal cells. Stem Cell Res Ther 12: 353

[39] Singh KP, Casado FL, Opanashuk LA, Gasiewicz TA (2009) The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem Pharmacol 77: 577- 587

[40] Sonoda Y (2008) Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection. J Autoimmun 30: 136- 144

[41] Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL (2014) The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol 32: 381- 386

[42] Wei Q, Frenette PS (2018) Niches for hematopoietic stem cells and their progeny. Immunity 48: 632- 648

[43] Wilkinson AC, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo RV, Yamamoto R, Loh KM, Nakamura Y, Watanabe M et al (2019a) Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature 571: 117- 121

[44] Wisniewski D, Affer M, Willshire J, Clarkson B (2011) Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia. Blood Cancer J 1: e36

[45] Xu Y, Shan W, Li X, Wang B, Liu S, Wang Y, Long Y, Tie R, Wang L, Cai S et al (2016) A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells. J Hematol Oncol 9: 102

[46] Yamashita M, Passegue E (2019) TNF-alpha coordinates hematopoietic stem cell survival and myeloid regeneration. Cell Stem Cell 25: 357- 372

[47] Zeng Y, He J, Bai Z, Li Z, Gong Y, Liu C, Ni Y, Du J, Ma C, Bian L et al (2019) Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing. Cell Res 29: 881- 894

RIGHTS & PERMISSIONS

2022 The Author(s)